TD Cowen Maintains Hold on Moderna, Raises Price Target to $90
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
TD Cowen analyst Tyler Van Buren maintains Moderna (NASDAQ:MRNA) with a Hold and raises the price target from $40 to $90.
TD Cowen analyst Tyler Van Buren maintains Moderna (NASDAQ:MRNA) with a Hold and raises the price target from $40 to $90.